Lenalidomide/Dexamethasone as Salvage Treatment in Mantle-Cell Lymphoma (MCL)
Zaja F et al. Salvage treatment with lenalidomide and dexamethasone in patients with relapsed or refractory mantle cell lymphoma: Clinical results and modifications of angiogenic biomarkers. Proc ASH 2010;Abstract 966.
Dr Cheson is Professor of Medicine, Head of Hematology and Director of Hematology Research at Georgetown University Hospital’s Lombardi Comprehensive Cancer Center in Washington, DC.
|